Free Online CME

≡ Menu

Medical Dermatology Therapy Update:
Autoimmune, Chronic Inflammatory,
and Advanced Malignant Diseases Online Monograph

Print this Content

Release Date:  October 15, 2018
Expiration Date:  October 15, 2020

Estimated Time of Completion:  1.0

Description

The online monograph provides up-to-date reviews of the most clinically important research data and an evidence-based update on traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition, an overview concerning the pathogenesis and diagnosis of various medical dermatologic diseases will be reviewed. Through a knowledgeable approach to therapeutic strategies, practitioners will be able to incorporate the latest research findings into their clinical practice for patients with medical dermatologic diseases, regardless of the extent of systemic involvement.

Learning Objectives

  • Summarize updates in knowledge concerning pathogenesis of various medical dermatologic diseases and how this relates to both drug development and use of traditional and modern therapeutic options

Target Audience

The educational activity is designed for physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Joseph English III, MD
Professor of Dermatology
University of Pittsburgh
Physicians Department of Dermatology-North Hills
Pittsburgh, PA

James Fernandez, MD, PhD
Department of Allergy and
Clinical Immunology
Cleveland Clinic
Cleveland, OH

Paul Hazen, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH

Shilpi Khetarpal, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH

Neil Korman, MD, PhD
Professor, Dermatology
Case Western Reserve University School of Medicine
Director, Murdough Family Center for Psoriasis
Director, Clinical Trials Unit
University Hospitals Cleveland Medical Center
Cleveland, OH

Melissa P. Piliang, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH

Misha A. Rosenbach, MD
Assistant Professor of Dermatology
Hospital of the University of Pennsylvania
Penn Medicine
Philadelphia, PA

Christine Warren, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH

Victoria P. Werth, MD
Professor of Dermatology and Medicine
Hospital of the University of Pennsylvania
Veteran’s Administration Medical Center
University of Pennsylvania School of Medicine
Chief, Dermatology
Philadelphia VA Medical Center
Penn Medicine
Philadelphia, PA

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:


Anthony P. Fernandez, MD
  Abbvie Pharmaceuticals Consulting; Independent contractor (including contracted research);
Teaching and Speaking
  Celgene Corporation Teaching and Speaking
  Mallinckrodt Inc. Independent contractor (including contracted research);
Teaching and Speaking
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
 
Paul Hazen, MD
  Abbvie Pharmaceuticals Consulting; Membership on advisory committee or review panels
Neil Korman, MD, PhD
  Immune Pharmaceuticals Inc Consulting; Membership on advisory committee or review panels
  Abbvie Pharmaceuticals Consulting; Membership on advisory committee or review panels;
Research; Teaching and Speaking
  Janssen Consulting; Membership on advisory committee or review panels;
Teaching and Speaking
  Novartis Consulting; Teaching and Speaking
  LEO Research
  Regeneron Teaching and Speaking
  Celgene Corporation, Eli Lilly, Pfizer, Inc. Consulting; Research
Victoria P. Werth, MD
  Biogen Idec, Celgene Corporation Consulting; Independent contractor (including contracted research);
Intellectual property rights (Royalties or patent sales);
Membership on advisory committee or review panels
  Idera, Octapharma Plasma, Medimmune, Neovacs, Resolve Therapeutics Consulting Intellectual property rights (Royalties or patent sales)
  Genentech/Roche, Gilead Sciences, Inc,.Janssen, Syntimmune Consulting; Independent contractor (including contracted research);
Intellectual property rights (Royalties or patent sales)
  Lilly Consulting; Membership on advisory committee or review panels
  ACI Clinical, Immune Pharmaceuticals Inc. Consulting
  Principia Biopharma Inc. Consulting; Intellectual property rights (Royalties or patent sales);
Membership on advisory committee or review panels
  BMS, CSL Behring, Pfizer Consulting; Intellectual property rights (Royalties or patent sales)

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Joseph English, III, MD
James Fernandez, MD, PhD
Shilpi Khetarpal, MD
Melissa P. Piliang, MD
Misha Rosenbach, MD
Christine Warren, MD

Acknowledgement
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

Abbvie, Inc.
Genentech
Lilly USA, LLC
Novartis Pharmaceuticals Corporation



The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:

Abbvie, Inc.
Celgene Corporation
Genentech
Genzyme Corporation
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Mallinckrodt, LLC
Novartis Pharmaceuticals Corporation
Pfizer
Valeant Pharmaceuticals North American, LLC

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and
Dermatology and Plastic Surgery Institute
.